Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Buprenorphine Stabilization and Induction Onto Vivitrol for Heroin-dependent Individuals
NCT03711318Phase 3Terminated
- Sponsor
- New York State Psychiatric Institute
- Start
- Nov 2018
- Primary completion
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine + naloxone in heroin dependence, sponsored by New York State Psychiatric Institute. Started Nov 2018; status: terminated.
02
Drugs
buprenorphine + naloxone
03
Conditions
heroin dependence
Beyond the preview
Go deeper on NCT03711318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03711318.